Zhang Bao
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
- MicroRNA in disease regulation 4
- Immunology top 10%
- Molecular Biology top 10%
- Muscle Physiology and Disorders 5
- Molecular Biology Techniques and Applications 4
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 7
-
- Lung Cancer Treatments and Mutations 5
-
- Cervical Cancer and HPV Research 4
-
- Cancer Immunotherapy and Biomarkers 4
Zhang Bao
79 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 268
- Complementary and alternative medicine 138
- Immunology 282
- Molecular Biology 716
- Infectious Diseases 174
Countries citing papers authored by Zhang Bao
This map shows the geographic impact of Zhang Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhang Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhang Bao more than expected).
Fields of papers citing papers by Zhang Bao
This network shows the impact of papers produced by Zhang Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhang Bao. The network helps show where Zhang Bao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhang Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 34 | |
| 3 | 2020 | 26 | |
| 4 | 2020 | 10 | |
| 5 | Identification and expression analysis of leucine-rich repeat receptor-like kinase family reveals the roles of resistance proteins during formation of replant disease in Rehmannia glutinosa. | 2019 | 2 |
| 6 | 2019 | 1 | |
| 7 | 2019 | 15 | |
| 8 | 2018 | 16 | |
| 9 | 2017 | 14 | |
| 10 | 2016 | 22 | |
| 11 | 2015 | 31 | |
| 12 | 2014 | 2 | |
| 13 | 2014 | 75 | |
| 14 | 2011 | 48 | |
| 15 | 2009 | 185 | |
| 16 | 2009 | 7 | |
| 17 | 2008 | 78 | |
| 18 | 2007 | 54 | |
| 19 | 2003 | 23 | |
| 20 | Complete Nucleotide Sequennce of the S Genome Segment of Hantavirus HTN261 Strain Isolated in the Northeast China | 2001 | 2 |
About Zhang Bao
Zhang Bao is a scholar working on Cancer Research, Infectious Diseases and Rehabilitation, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Muscle Physiology and Disorders (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Molecular Biology Techniques and Applications (4 papers), Cervical Cancer and HPV Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (268 citations), Complementary and alternative medicine (138 citations) and Immunology (282 citations). Zhang Bao has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include W.S. Fred Wong, Bernard P. Leung, Jianying Zhou, Cheng Chang, Siew Heng Wong, D.M. Kemeny, Yinan Yao, Guangdie Yang, Guohua Lu and Wupeng Liao. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.